Lysozymes – Efficient Protein Recovery
The lysis of bacterial cells is an important step in biopharmaceutical production processes. To help you achieve consistent, high yields from your therapeutic protein production process, Merck offers a set of lysozymes that now includes CellPrime® recombinant human lysozyme (rLysozyme).
Specifically designed for use in biopharmaceutical production processes and life science research, CellPrime® rLysozyme is a powerful recombinant enzyme that exhibits a 3.4 fold higher specific activity than the enzyme prepared from chicken egg white. Since CellPrime® recombinant human lysozyme is of non-animal origin, it also eliminates the risk of infectious disease transmission. CellPrime® recombinant human lysozyme is available in various pack sizes, including bulk amounts suitable for use in large scale processing.